2012 annual financial data
Ernexa Therapeutics 2012 Operating cash flow margin
Ernexa Therapeutics 2012 operating cash flow margin with verified reported valu…
Direct answer
Operating cash flow margin was 8.96%.
Operating income was -1,062,000 USD and net income was -995,000 USD.
Operating cash flow was 2,156,000 USD.
Get free Ernexa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 24,064,000 USD
- Operating income
- -1,062,000 USD
- Net income
- -995,000 USD
- Operating cash flow
- 2,156,000 USD